IASLC World Conference on Lung Cancer 2023 Press Briefing Sunday, September 10, 2023

Today's briefing, moderated by Dr. Brendon Stiles, featured the following presentations:
Benmelstobar with Anlotinib plus Chemotherapy as First-line Therapy for ES-SCLC: A Randomized, Double-blind, Phase III Trial, with Dr. Ying Cheng
Treatment response in malignant pleural mesothelioma patients can be predicted by exhaled breath analysis, with Dr. Kevin Lamote
KRYSTAL-1: Two-Year Follow-Up of Adagrasib (MRTX849) Monotherapy in Patients with Advanced/Metastatic KRASG12C-Mutated NSCLC, with Dr. Shirish Gadgeel
Stigma-Reducing Interventions for Lung Cancer and Other Smoking-Related Respiratory Diseases: A Systematic Review, with Dr. Nathan Harrison and Jill Feldman
Six-year survival and HRQoL outcomes with 1L nivolumab + ipilimumab in patients with metastatic NSCLC from CheckMate227, with Dr. Solange Peters
Lung Cancer Patient Advocate Janet Freeman-Daily provide a summary of the research, from the patient perspective.